U.S. markets closed

FibroGen, Inc. (FGEN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
0.6284+0.0760 (+13.76%)
At close: 04:00PM EST
0.6310 +0.00 (+0.41%)
After hours: 07:21PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected


Previous Close0.5524
Bid0.6310 x 2900
Ask0.6500 x 1100
Day's Range0.5500 - 0.6400
52 Week Range0.3330 - 25.6900
Avg. Volume3,743,245
Market Cap61.797M
Beta (5Y Monthly)0.53
PE Ratio (TTM)N/A
EPS (TTM)-3.0600
Earnings DateFeb 26, 2024 - Mar 01, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.03
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for FGEN

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • FibroGen, Inc
    DVA: Raising target price to $110.00DAVITA INC has an Investment Rating of BUY; a target price of $110.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of High; a Growth Subrating of High; and a Value Subrating of High.
    Fair Value
    Economic Moat
    3 days agoArgus Research
View more